Lymph Node–Positive Kidney Disease: Future Implications of PET Imaging

Lymph Node Management and Molecular Imaging

Main Discussion Topics:

• The current approach typically limits lymph node dissection to radiographically evident disease.
• Molecular imaging could identify nodal disease missed by conventional imaging.
• Detection of nodal disease by molecular imaging would be actionable.
• Could influence surgical planning or shift patients toward systemic therapy approaches

Key Points for Physicians:

• Neither expert routinely performs lymph node dissection without radiographic indication.
• A positive node on molecular imaging would likely change management.
• Options include targeted lymph node dissection or initiation of systemic therapy.
• Improved node detection could help homogenize treatment groups in clinical trials.

Notable Insights:

Nodal disease detected by molecular imaging is considered biologically significant and likely indicates systemic disease requiring more than surgery alone.

Clinical Significance:

Molecular imaging could fundamentally change nodal staging and management decisions, potentially moving patients from surgery-first approaches to systemic therapy.